Our MSc student Angelos Michailidis at Regeneron Pharmaceuticals, Inc.for his one-year MSc Thesis internship in the leading American biotechnology company

Congratulations to our current MSc Student Angelos MICHAILIDIS (Class 2022-2024, 2nd year), who has recently joined the American biotechnology company Regeneron Phamaceuticals, Inc., located in New York, United States, in order to perform his Master's Thesis Dissertation internship.

Following his laboratory short internships (rotations) in the Athens area, Greece, Angelos is now being trained at the Regeneron's Corporate Headquarters, in Human Systems Department, located in the Tarrytown Campus, NY, under the supervision of Dr. Katia KARALIS, Executive Director Research and Development, Head of Human Systems for Disease Modeling and Drug Development, and one of our long-term collaborator and lecturer in the International MSc Molecular Biomedicine program.

Founded in 1988 by scientists Leonard S. Schleifer and George D. Yancopoulos, the leading biotechnology company is dedicated to inventing life-transforming medicines to help people with serious diseases. Their science-driven approach includes research in eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases and rare diseases. Regeneron's ability to translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in the company's laboratories.